Ubaldo Arturo Pimentel Aguilar
Benemerita Universidad De Puebla, Mexico
Title: Inflammatory Bowel Disease: Therapy
Biography
Biography: Ubaldo Arturo Pimentel Aguilar
Abstract
Many therapies are avaible for patients with inflammatory bowel disease (IBD). Medical therapies include aminoslicylates drugs such as sulfasalazine, olsalazine, balsalazide, and various formulations of mesalamine; antibiotics; corticosteroids; immunosuppresive medications as azathiprine, 6-mercaptopurine (6-MP), methotrexate, and cyclosporine; and biotechnology medications such as anti-tumor necrosis factor (TNF) agents and newer agents with different mechanisms of action. Many surgical therapies also are used in patients with IBD. Some of the treatments are designed to deliver medication to specific areas of the bowel, while others act systemically. A thorough understanding of the anatomical distribution og inflammation is required in order to choose the optimal drug for a given patient. Ulcerative colitis can be divided into ulcerative proctitis, ulcerative proctosigmoiditis, left- sided ulcerative colitis, and extensive colitis or pancolitis. Crohn disease can be divided into ileitis, colitis, and ileocolitis.